55 results
6-K
EX-99.1
GNFT
Genfit
25 Apr 24
Current report (foreign)
4:10pm
impact of its activity, and its low environmental footprint, could create meaningful long-term value for patients, healthcare systems, employees … and shareholders, and assure the Company’s growth and long- term future.
ABOUT GENFIT
GENFIT is a late-stage biopharmaceutical company committed
6-K
EX-99.1
0j8vee8u
8 Dec 23
Current report (foreign)
8:00am
6-K
EX-99.1
xh4ecm1gfr7bolojdilr
7 Dec 23
Ipsen confirms U.S. FDA grants priority review for New Drug Application for elafibranor for the treatment of rare cholestatic liver disease, PBC
6:37am
6-K
EX-99.1
6x1qel1trg139gs5
6 Dec 23
Current report (foreign)
11:30am
6-K
EX-99.1
m0q9j0pxrjv vuqa
13 Nov 23
Current report (foreign)
4:30pm
6-K
EX-99.1
fqfv5
20 Sep 23
Current report (foreign)
4:44pm
6-K
EX-99.1
jqjlxeo0p5ark27
30 Jun 23
Current report (foreign)
6:00am
6-K
EX-99.1
i27cj2u2
28 Apr 23
GENFIT Announces Publication of Extra-Financial Performance Report 2022
6:00am
F-3
lcyqfff49jde456g59at
18 Apr 23
Shelf registration (foreign)
2:33pm
6-K
EX-99.2
5l2b03ojwr1g455lbg
28 Sep 22
GENFIT Reports First Half-Year 2022 Financial Results and Provides Corporate Update
4:13pm
6-K
EX-99.1
sivi fznv23ka0
25 May 22
Current report (foreign)
4:10pm
6-K
EX-99.1
fg7o2h xygi
11 May 22
GENFIT Reports First Quarter 2022 Financial Information
4:10pm